Physitrack PLC reported earnings results for the fourth quarter and thirteen months ended December 31, 2021. For the fourth quarter, the company reported sales was EUR 2.58 million compared to EUR 0.912074 million a year ago. Net income was EUR 0.030914 million compared to EUR 0.107133 million a year ago.
For the thirteen months, sales was EUR 8.47 million. Net loss was EUR 0.882954 million. Basic loss per share from continuing operations was EUR 0.06. Diluted loss per share from continuing operations was EUR 0.06.